So-hee Lee
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clusterin inhibits lipopolysaccharide induced liver injury.
Journal: Scientific reports
Published: July 22, 2024
Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver.
Journal: PloS one
Published: May 13, 2023
Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells.
Journal: International journal of molecular sciences
Published: August 26, 2022
In Vitro and In Vivo Protective Effects of Lentil (Lens culinaris) Extract against Oxidative Stress-Induced Hepatotoxicity.
Journal: Molecules (Basel, Switzerland)
Published: October 29, 2021
Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway.
Journal: International journal of molecular sciences
Published: September 07, 2021
Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connetive Tissue Growth Factor.
Journal: Cells
Published: January 29, 2020
Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway.
Journal: Cells
Published: September 26, 2019
Kahweol Ameliorates the Liver Inflammation through the Inhibition of NF-κB and STAT3 Activation in Primary Kupffer Cells and Primary Hepatocytes.
Journal: Nutrients
Published: June 07, 2018
Kahweol decreases hepatic fibrosis by inhibiting the expression of connective tissue growth factor via the transforming growth factor-beta signaling pathway.
Journal: Oncotarget
Published: January 17, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026